BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 10370679)

  • 1. Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies.
    Acevedo J
    World J Hepatol; 2015 May; 7(7):916-21. PubMed ID: 25954474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice.
    Ferrarese A; Passigato N; Cusumano C; Gemini S; Tonon A; Dajti E; Marasco G; Ravaioli F; Colecchia A
    World J Hepatol; 2021 Aug; 13(8):840-852. PubMed ID: 34552691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream Infection and Its Clinical Characteristics and Relevant Factors Associated with Interventional Therapy in a Large Tertiary Hospital: A Six Years Surveillance Study.
    Bai Y; Zheng Z; Du M; Yao H; Liu Y; Suo J
    Biomed Res Int; 2019; 2019():8190475. PubMed ID: 31781645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival with the patients with variceal bleed.
    Sharma P; Sarin SK
    Int J Hepatol; 2011; 2011():356919. PubMed ID: 21994853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.
    Chavez-Tapia NC; Barrientos-Gutierrez T; Tellez-Avila FI; Soares-Weiser K; Uribe M
    Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD002907. PubMed ID: 20824832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review.
    Zilberberg MD; Chen J; Mody SH; Ramsey AM; Shorr AF
    BMC Pulm Med; 2010 Aug; 10():45. PubMed ID: 20796312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of portosystemic bacterial translocation in patients with liver cirrhosis after placement of transjugular shunt.
    Cohnen M; Lüthen R; Däubener W; Mödder U
    Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):310-2. PubMed ID: 12734723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update.
    Zheng M; Chen Y; Bai J; Zeng Q; You J; Jin R; Zhou X; Shen H; Zheng Y; Du Z
    J Clin Gastroenterol; 2008; 42(5):507-16. PubMed ID: 18344888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.
    Gulberg V; Deibert P; Ochs A; Rossle M; Gerbes AL
    Hepatogastroenterology; 1999; 46(26):1126-30. PubMed ID: 10370679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.
    Pozler O; Krajina A; Vanicek H; Hulek P; Zizka J; Michl A; Elias P
    Hepatogastroenterology; 2003; 50(52):1111-4. PubMed ID: 12845992
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.